Subchronic alpha- and beta-adrenergic regulation of cardiac gap junction protein expression

ABSTRACT Gap junction channels are essential for intercellular electrical communication in the heart. The most important cardiac gap junction proteins are connexin43 (predominantly) (Cx43), connexin40 (Cx40), and in early developmental stages connexin45. Since catecholamines play an important role i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The FASEB journal 2006-02, Vol.20 (2), p.365-367
Hauptverfasser: Salameh, A, Frenzel, C, Boldt, A, Rassler, B, Glawe, I, Schulte, J, Můhlberg, K, Zimmer, H.-G, Pfeiffer, D, Dhein, S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 367
container_issue 2
container_start_page 365
container_title The FASEB journal
container_volume 20
creator Salameh, A
Frenzel, C
Boldt, A
Rassler, B
Glawe, I
Schulte, J
Můhlberg, K
Zimmer, H.-G
Pfeiffer, D
Dhein, S
description ABSTRACT Gap junction channels are essential for intercellular electrical communication in the heart. The most important cardiac gap junction proteins are connexin43 (predominantly) (Cx43), connexin40 (Cx40), and in early developmental stages connexin45. Since catecholamines play an important role in cardiac (patho)physiology, we wanted to elucidate whether catecholamines may affect expression of Cx43 and Cx40. Cultured neonatal rat cardiomyocytes were exposed for 24 h to increasing concentrations of noradrenaline (1–10000 nM) (physiological agonist at α and β‐adrenoceptors), resulting in significantly increased Cx43‐expression, while Cx40 was unaffected. In further experiments cells were incubated with either phenylephrine (α‐adrenergic agonist) or isoproterenol (β‐adrenergic agonist) (0.1–1000 nM) for 24 h. Both catecholamines lead to a concentration‐dependent increase in Cx43 protein and mRNA expression (EC50: 10–20 nM). Inhibition experiments showed that the phenylephrine effect was transduced via PKC, while the isoproterenol effect was mediated by PKA. Dual whole‐cell voltage clamp demonstrated that increased Cx43‐expression was accompanied by significant increases in gap junction current. In additional in vivo experiments, adult rats were subjected to 24‐h infusion of isoproterenol or phenylephrine showing again significant increase in Cx43 but not Cx40. Adrenergic stimulation of cardiomyocytes can enhance Cx43 expression thereby increasing cellular coupling, indicating a possible role for catecholamines in the regulation of cardiac gap junction expression in cardiac disease.
doi_str_mv 10.1096/fj.05-4871fje
format Article
fullrecord <record><control><sourceid>wiley_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1096_fj_05_4871fje</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>FSB2FJ054871FJE</sourcerecordid><originalsourceid>FETCH-LOGICAL-c432E-9d101e224eb8be11616cc14aa1e440618433af934ebf2f5f36b7cd95cab723b23</originalsourceid><addsrcrecordid>eNp9kM1OwzAQhC0EoqVw5Ap-ARf_JE7CDaoGqCpxKD1xsNaOnSZKk8hpBH17UlqJG6fV7nwzWg1Ct4xOGU3kgyunNCRBHDFX2jM0ZqGgRMaSnqMxjRNOpBTxCF11XUkpZZTJSzRiUoRcBvEYfa56bTa-qQuDoWo3QDDUGdZ2BwQyb2vr80HyNu8r2BVNjRuHDfisAINzaHHZ1-b33vpmZ4sa2-_W264bTtfowkHV2ZvTnKB1Ov-YvZLl-8vb7GlJTCD4nCTZ8JXlPLA61pYxyaQxLABgNgioZHEgBLhEDLrjLnRC6shkSWhAR1xoLiaIHHONb7rOW6daX2zB7xWj6lCScqWioTqVNPB3R77t9dZmf_SplQF4PAJfRWX3_6epdPXM0wUND3u6mA_m-6PZQaMg90Wn1itOmRjKD3kkufgBrr5_kg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Subchronic alpha- and beta-adrenergic regulation of cardiac gap junction protein expression</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Alma/SFX Local Collection</source><creator>Salameh, A ; Frenzel, C ; Boldt, A ; Rassler, B ; Glawe, I ; Schulte, J ; Můhlberg, K ; Zimmer, H.-G ; Pfeiffer, D ; Dhein, S</creator><creatorcontrib>Salameh, A ; Frenzel, C ; Boldt, A ; Rassler, B ; Glawe, I ; Schulte, J ; Můhlberg, K ; Zimmer, H.-G ; Pfeiffer, D ; Dhein, S</creatorcontrib><description>ABSTRACT Gap junction channels are essential for intercellular electrical communication in the heart. The most important cardiac gap junction proteins are connexin43 (predominantly) (Cx43), connexin40 (Cx40), and in early developmental stages connexin45. Since catecholamines play an important role in cardiac (patho)physiology, we wanted to elucidate whether catecholamines may affect expression of Cx43 and Cx40. Cultured neonatal rat cardiomyocytes were exposed for 24 h to increasing concentrations of noradrenaline (1–10000 nM) (physiological agonist at α and β‐adrenoceptors), resulting in significantly increased Cx43‐expression, while Cx40 was unaffected. In further experiments cells were incubated with either phenylephrine (α‐adrenergic agonist) or isoproterenol (β‐adrenergic agonist) (0.1–1000 nM) for 24 h. Both catecholamines lead to a concentration‐dependent increase in Cx43 protein and mRNA expression (EC50: 10–20 nM). Inhibition experiments showed that the phenylephrine effect was transduced via PKC, while the isoproterenol effect was mediated by PKA. Dual whole‐cell voltage clamp demonstrated that increased Cx43‐expression was accompanied by significant increases in gap junction current. In additional in vivo experiments, adult rats were subjected to 24‐h infusion of isoproterenol or phenylephrine showing again significant increase in Cx43 but not Cx40. Adrenergic stimulation of cardiomyocytes can enhance Cx43 expression thereby increasing cellular coupling, indicating a possible role for catecholamines in the regulation of cardiac gap junction expression in cardiac disease.</description><identifier>ISSN: 0892-6638</identifier><identifier>EISSN: 1530-6860</identifier><identifier>DOI: 10.1096/fj.05-4871fje</identifier><identifier>PMID: 16352648</identifier><language>eng</language><publisher>United States: Federation of American Societies for Experimental Biology</publisher><subject>Adrenergic alpha-Agonists - pharmacology ; Adrenergic beta-Agonists - pharmacology ; alpha‐adrenoceptor ; Animals ; beta‐adrenoceptor ; cardiomyocytes ; catecholamine • noradrenaline ; Cells, Cultured ; Connexin 43 - genetics ; Connexin 43 - metabolism ; connexins ; Connexins - genetics ; Connexins - metabolism ; dual whole‐cell voltage clamp ; Gap Junction alpha-5 Protein ; Gap Junctions - metabolism ; Gene Expression Regulation - drug effects ; Isoproterenol - pharmacology ; Myocytes, Cardiac - metabolism ; Phenylephrine - pharmacology ; Rats ; Rats, Wistar ; Receptors, Adrenergic, alpha - metabolism ; Receptors, Adrenergic, beta - metabolism</subject><ispartof>The FASEB journal, 2006-02, Vol.20 (2), p.365-367</ispartof><rights>FASEB</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c432E-9d101e224eb8be11616cc14aa1e440618433af934ebf2f5f36b7cd95cab723b23</citedby><cites>FETCH-LOGICAL-c432E-9d101e224eb8be11616cc14aa1e440618433af934ebf2f5f36b7cd95cab723b23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1096%2Ffj.05-4871fje$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1096%2Ffj.05-4871fje$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16352648$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Salameh, A</creatorcontrib><creatorcontrib>Frenzel, C</creatorcontrib><creatorcontrib>Boldt, A</creatorcontrib><creatorcontrib>Rassler, B</creatorcontrib><creatorcontrib>Glawe, I</creatorcontrib><creatorcontrib>Schulte, J</creatorcontrib><creatorcontrib>Můhlberg, K</creatorcontrib><creatorcontrib>Zimmer, H.-G</creatorcontrib><creatorcontrib>Pfeiffer, D</creatorcontrib><creatorcontrib>Dhein, S</creatorcontrib><title>Subchronic alpha- and beta-adrenergic regulation of cardiac gap junction protein expression</title><title>The FASEB journal</title><addtitle>FASEB J</addtitle><description>ABSTRACT Gap junction channels are essential for intercellular electrical communication in the heart. The most important cardiac gap junction proteins are connexin43 (predominantly) (Cx43), connexin40 (Cx40), and in early developmental stages connexin45. Since catecholamines play an important role in cardiac (patho)physiology, we wanted to elucidate whether catecholamines may affect expression of Cx43 and Cx40. Cultured neonatal rat cardiomyocytes were exposed for 24 h to increasing concentrations of noradrenaline (1–10000 nM) (physiological agonist at α and β‐adrenoceptors), resulting in significantly increased Cx43‐expression, while Cx40 was unaffected. In further experiments cells were incubated with either phenylephrine (α‐adrenergic agonist) or isoproterenol (β‐adrenergic agonist) (0.1–1000 nM) for 24 h. Both catecholamines lead to a concentration‐dependent increase in Cx43 protein and mRNA expression (EC50: 10–20 nM). Inhibition experiments showed that the phenylephrine effect was transduced via PKC, while the isoproterenol effect was mediated by PKA. Dual whole‐cell voltage clamp demonstrated that increased Cx43‐expression was accompanied by significant increases in gap junction current. In additional in vivo experiments, adult rats were subjected to 24‐h infusion of isoproterenol or phenylephrine showing again significant increase in Cx43 but not Cx40. Adrenergic stimulation of cardiomyocytes can enhance Cx43 expression thereby increasing cellular coupling, indicating a possible role for catecholamines in the regulation of cardiac gap junction expression in cardiac disease.</description><subject>Adrenergic alpha-Agonists - pharmacology</subject><subject>Adrenergic beta-Agonists - pharmacology</subject><subject>alpha‐adrenoceptor</subject><subject>Animals</subject><subject>beta‐adrenoceptor</subject><subject>cardiomyocytes</subject><subject>catecholamine • noradrenaline</subject><subject>Cells, Cultured</subject><subject>Connexin 43 - genetics</subject><subject>Connexin 43 - metabolism</subject><subject>connexins</subject><subject>Connexins - genetics</subject><subject>Connexins - metabolism</subject><subject>dual whole‐cell voltage clamp</subject><subject>Gap Junction alpha-5 Protein</subject><subject>Gap Junctions - metabolism</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Isoproterenol - pharmacology</subject><subject>Myocytes, Cardiac - metabolism</subject><subject>Phenylephrine - pharmacology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptors, Adrenergic, alpha - metabolism</subject><subject>Receptors, Adrenergic, beta - metabolism</subject><issn>0892-6638</issn><issn>1530-6860</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1OwzAQhC0EoqVw5Ap-ARf_JE7CDaoGqCpxKD1xsNaOnSZKk8hpBH17UlqJG6fV7nwzWg1Ct4xOGU3kgyunNCRBHDFX2jM0ZqGgRMaSnqMxjRNOpBTxCF11XUkpZZTJSzRiUoRcBvEYfa56bTa-qQuDoWo3QDDUGdZ2BwQyb2vr80HyNu8r2BVNjRuHDfisAINzaHHZ1-b33vpmZ4sa2-_W264bTtfowkHV2ZvTnKB1Ov-YvZLl-8vb7GlJTCD4nCTZ8JXlPLA61pYxyaQxLABgNgioZHEgBLhEDLrjLnRC6shkSWhAR1xoLiaIHHONb7rOW6daX2zB7xWj6lCScqWioTqVNPB3R77t9dZmf_SplQF4PAJfRWX3_6epdPXM0wUND3u6mA_m-6PZQaMg90Wn1itOmRjKD3kkufgBrr5_kg</recordid><startdate>200602</startdate><enddate>200602</enddate><creator>Salameh, A</creator><creator>Frenzel, C</creator><creator>Boldt, A</creator><creator>Rassler, B</creator><creator>Glawe, I</creator><creator>Schulte, J</creator><creator>Můhlberg, K</creator><creator>Zimmer, H.-G</creator><creator>Pfeiffer, D</creator><creator>Dhein, S</creator><general>Federation of American Societies for Experimental Biology</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200602</creationdate><title>Subchronic alpha- and beta-adrenergic regulation of cardiac gap junction protein expression</title><author>Salameh, A ; Frenzel, C ; Boldt, A ; Rassler, B ; Glawe, I ; Schulte, J ; Můhlberg, K ; Zimmer, H.-G ; Pfeiffer, D ; Dhein, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c432E-9d101e224eb8be11616cc14aa1e440618433af934ebf2f5f36b7cd95cab723b23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adrenergic alpha-Agonists - pharmacology</topic><topic>Adrenergic beta-Agonists - pharmacology</topic><topic>alpha‐adrenoceptor</topic><topic>Animals</topic><topic>beta‐adrenoceptor</topic><topic>cardiomyocytes</topic><topic>catecholamine • noradrenaline</topic><topic>Cells, Cultured</topic><topic>Connexin 43 - genetics</topic><topic>Connexin 43 - metabolism</topic><topic>connexins</topic><topic>Connexins - genetics</topic><topic>Connexins - metabolism</topic><topic>dual whole‐cell voltage clamp</topic><topic>Gap Junction alpha-5 Protein</topic><topic>Gap Junctions - metabolism</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Isoproterenol - pharmacology</topic><topic>Myocytes, Cardiac - metabolism</topic><topic>Phenylephrine - pharmacology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptors, Adrenergic, alpha - metabolism</topic><topic>Receptors, Adrenergic, beta - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Salameh, A</creatorcontrib><creatorcontrib>Frenzel, C</creatorcontrib><creatorcontrib>Boldt, A</creatorcontrib><creatorcontrib>Rassler, B</creatorcontrib><creatorcontrib>Glawe, I</creatorcontrib><creatorcontrib>Schulte, J</creatorcontrib><creatorcontrib>Můhlberg, K</creatorcontrib><creatorcontrib>Zimmer, H.-G</creatorcontrib><creatorcontrib>Pfeiffer, D</creatorcontrib><creatorcontrib>Dhein, S</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>The FASEB journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Salameh, A</au><au>Frenzel, C</au><au>Boldt, A</au><au>Rassler, B</au><au>Glawe, I</au><au>Schulte, J</au><au>Můhlberg, K</au><au>Zimmer, H.-G</au><au>Pfeiffer, D</au><au>Dhein, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Subchronic alpha- and beta-adrenergic regulation of cardiac gap junction protein expression</atitle><jtitle>The FASEB journal</jtitle><addtitle>FASEB J</addtitle><date>2006-02</date><risdate>2006</risdate><volume>20</volume><issue>2</issue><spage>365</spage><epage>367</epage><pages>365-367</pages><issn>0892-6638</issn><eissn>1530-6860</eissn><abstract>ABSTRACT Gap junction channels are essential for intercellular electrical communication in the heart. The most important cardiac gap junction proteins are connexin43 (predominantly) (Cx43), connexin40 (Cx40), and in early developmental stages connexin45. Since catecholamines play an important role in cardiac (patho)physiology, we wanted to elucidate whether catecholamines may affect expression of Cx43 and Cx40. Cultured neonatal rat cardiomyocytes were exposed for 24 h to increasing concentrations of noradrenaline (1–10000 nM) (physiological agonist at α and β‐adrenoceptors), resulting in significantly increased Cx43‐expression, while Cx40 was unaffected. In further experiments cells were incubated with either phenylephrine (α‐adrenergic agonist) or isoproterenol (β‐adrenergic agonist) (0.1–1000 nM) for 24 h. Both catecholamines lead to a concentration‐dependent increase in Cx43 protein and mRNA expression (EC50: 10–20 nM). Inhibition experiments showed that the phenylephrine effect was transduced via PKC, while the isoproterenol effect was mediated by PKA. Dual whole‐cell voltage clamp demonstrated that increased Cx43‐expression was accompanied by significant increases in gap junction current. In additional in vivo experiments, adult rats were subjected to 24‐h infusion of isoproterenol or phenylephrine showing again significant increase in Cx43 but not Cx40. Adrenergic stimulation of cardiomyocytes can enhance Cx43 expression thereby increasing cellular coupling, indicating a possible role for catecholamines in the regulation of cardiac gap junction expression in cardiac disease.</abstract><cop>United States</cop><pub>Federation of American Societies for Experimental Biology</pub><pmid>16352648</pmid><doi>10.1096/fj.05-4871fje</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0892-6638
ispartof The FASEB journal, 2006-02, Vol.20 (2), p.365-367
issn 0892-6638
1530-6860
language eng
recordid cdi_crossref_primary_10_1096_fj_05_4871fje
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Alma/SFX Local Collection
subjects Adrenergic alpha-Agonists - pharmacology
Adrenergic beta-Agonists - pharmacology
alpha‐adrenoceptor
Animals
beta‐adrenoceptor
cardiomyocytes
catecholamine • noradrenaline
Cells, Cultured
Connexin 43 - genetics
Connexin 43 - metabolism
connexins
Connexins - genetics
Connexins - metabolism
dual whole‐cell voltage clamp
Gap Junction alpha-5 Protein
Gap Junctions - metabolism
Gene Expression Regulation - drug effects
Isoproterenol - pharmacology
Myocytes, Cardiac - metabolism
Phenylephrine - pharmacology
Rats
Rats, Wistar
Receptors, Adrenergic, alpha - metabolism
Receptors, Adrenergic, beta - metabolism
title Subchronic alpha- and beta-adrenergic regulation of cardiac gap junction protein expression
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T04%3A21%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Subchronic%20alpha-%20and%20beta-adrenergic%20regulation%20of%20cardiac%20gap%20junction%20protein%20expression&rft.jtitle=The%20FASEB%20journal&rft.au=Salameh,%20A&rft.date=2006-02&rft.volume=20&rft.issue=2&rft.spage=365&rft.epage=367&rft.pages=365-367&rft.issn=0892-6638&rft.eissn=1530-6860&rft_id=info:doi/10.1096/fj.05-4871fje&rft_dat=%3Cwiley_cross%3EFSB2FJ054871FJE%3C/wiley_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/16352648&rfr_iscdi=true